Literature DB >> 10858394

Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis.

T Y Martinez1, C A Pereira, M L dos Santos, R M Ciconelli, S M Guimarães, J A Martinez.   

Abstract

OBJECTIVE: To validate the use of the 36-item short-form questionnaire (SF-36) for measuring health-related quality of life (HRQL) in patients with idiopathic pulmonary fibrosis (IPF).
DESIGN: : Observational data at a single point in time.
SETTING: : A specialized outpatient respiratory clinic. PARTICIPANTS: Thirty-four patients (mean +/- SE age, 58.29 +/- 1.87 years) with IPF and no significant comorbidity. A matched control group for HRQL measurements was composed of 34 normal subjects (mean age, 58.00 +/- 1.89 years). MEASUREMENTS AND
RESULTS: Dyspnea was measured by the baseline dyspnea index (BDI). Respiratory function evaluation included FVC, FEV(1), and resting arterial blood gases. IPF patients showed a mean BDI score of 5.21 +/- 0.46. The mean FVC and FEV(1) values were 62.41 +/- 2.96% and 66.41 +/- 3.33%, respectively. The mean PaO(2) was 67 +/- 2.51 mm Hg, and the mean PaCO(2) was 37 +/- 1. 05 mm Hg. Patients scored significantly worse than control subjects with respect to the SF-36 domains of physical functioning, physical role, general health perceptions, vitality, social functioning, emotional role, and mental health index. BDI scores were significantly correlated with five SF-36 components, and FVC and FEV(1) were significantly correlated with two SF-36 components. Significant negative correlations were found between arterial pH and four SF-36 domains.
CONCLUSIONS: Patients with IPF have a significant impairment of HRQL in both physical and psychological functioning. Dyspnea is the most important factor influencing the quality of life in these subjects. The SF-36 questionnaire is a valid instrument to evaluate HRQL in IPF patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858394     DOI: 10.1378/chest.117.6.1627

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  38 in total

1.  Burden, resilience and coping in caregivers of patients with interstitial lung disease.

Authors:  R J Shah; H R Collard; J Morisset
Journal:  Heart Lung       Date:  2018-04-04       Impact factor: 2.210

2.  Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina Antoniou; Georgios Papadogiannis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2014-07-16       Impact factor: 2.816

Review 3.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Meilan Han; Rekha Vij; Imre Noth; Eric L Eisenstein; Kevin J Anstrom; Kevin K Brown; Diane Fairclough
Journal:  Respir Med       Date:  2012-07-15       Impact factor: 3.415

5.  Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

Authors:  Janelle Yorke; Jeffrey Swigris; Anne-Marie Russell; Shakeeb H Moosavi; Georges Ng Man Kwong; Mark Longshaw; Paul W Jones
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

6.  Sleep disorders and health-related quality of life in patients with interstitial lung disease.

Authors:  Maria Mavroudi; Despoina Papakosta; Theodore Kontakiotis; Kaliopi Domvri; George Kalamaras; Vasiliki Zarogoulidou; Paul Zarogoulidis; Paschalina Latka; Haidong Huang; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Sleep Breath       Date:  2017-10-16       Impact factor: 2.816

7.  CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina M Antoniou; Demetrios Mermigkis; Kostas Psathakis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

8.  Quality of life in patients with glaucoma who live in a developing country.

Authors:  Marcela C Cypel; Niro Kasahara; Denise Atique; Cristiano C Umbelino; Mônica P A Alcântara; Francisco S Seixas; Geraldo V de Almeida; Carmo Mandia; Ralph Cohen
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

9.  Effect of lung fibrosis on glycogen content in different extrapulmonary tissues.

Authors:  Elizabeth Lage Borges; Marina de Barros Pinheiro; Luana Oliveira Prata; Wesley Araújo Sales; Yuri Augusto Junqueira Belém Silva; Marcelo Vidigal Caliari; Maria Glória Rodrigues-Machado; Maria da Glória Rodrigues-Machado
Journal:  Lung       Date:  2013-12-03       Impact factor: 2.584

10.  Quality-of-life evaluation for patients submitted to nasal endoscopic surgery for resection of pituitary tumours.

Authors:  Ricardo Landini Lutaif Dolci; Lígia Tédde de Moraes; Ana Carolina Mayor de Carvalho; Jeniffer Cristina Kozechen Rickli; Jamile Lopes de Souza; Williams Escalante Encinas; José Viana Lima Junior; Nilza Maria Scalissi; Américo Rubens Leite Dos Santos; Paulo Roberto Lazarini
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.